Quick search
Advanced search in
Research outcomes
Field to searchTerm
Add rule
Filters (1)
Filters
Clear All
COVID-19Other research productsEmbargo
The following results are related to COVID-19. Are you interested to view more results? Visit OpenAIRE - Explore.
Download Results
6 research outcomes, page 1 of 1
  • other research product . Other ORP type . 2020 . Embargo End Date: 06 Jun 2021
    Vitamin D Supplementation During the COVID-19 Pandemic
    Embargo English
    Authors:
    Siuka, Darko; Pfeifer, Marija; Pinter, Bojana;
    Persistent Identifiers

    doi: 10.1016/j.mayocp.2020.05.036

    Publisher: Elsevier, Mayo Foundation
    Add to ORCID
  • other research product . Other ORP type . 2020 . Embargo End Date: 26 Aug 2021
    An increase in kidney transplantation procedures from deceased donors during the COVID-19 epidemic in Slovenia
    Embargo English
    Authors:
    Arnol, Miha; Smrkolj, Tomaž; Avsec, Danica; Gadžijev, Andrej; Kneževič, Ivan;
    Persistent Identifiers

    doi: 10.1111/tri.13715

    Publisher: Springer-Verl. New York, Springer
    Add to ORCID
  • other research product . Other ORP type . 2020 . Embargo End Date: 02 Sep 2021
    Telemedicine in radiation oncology post-COVID-19 pandemic
    Embargo English
    Authors:
    Oražem, Miha; Oblak, Irena; Španić, Tanja; Ratoša, Ivica;
    Persistent Identifiers

    doi: 10.1016/j.ijrobp.2020.06.052

    Publisher: Elsevier, American Society for Radiation Oncology

    Purpose We aimed to assess patients’ and physicians’ perspectives on wider implementation of telemedicine in radiation oncology practice, disrupted by the novel coronavirus disease 2019 (COVID-19). Methods Quantitative questionnaires were prepared and distributed betwee...

    Add to ORCID
  • other research product . 2020
    Reply to A. Lasagna et al
    Embargo English
    Authors:
    Figuero-Perez, Luis; Olivares-Hernández, Alejandro; Escala-Cornejo, Roberto A.; Cruz, Juan Jesús;
    Persistent Identifiers

    doi: 10.1200/op.20.00640

    handle: 10261/231227

    Publisher: American Society of Clinical Oncology

    We thank Lasagna et al1 for their letter in response to our recent report.2 In our article, we discussed the management of febrile neutropenia associated with a SARS-CoV-2 infection in a patient with lung cancer. The disease presented a favorable evolution with spontane...

    Add to ORCID
  • other research product . 2020
    Host or pathogen-related factors in COVID-19 severity?
    Embargo English
    Authors:
    Gortázar, Christian; Rodríguez del‐Río, Francisco J.; Domínguez, Lucas; Fuente, José de la;
    Persistent Identifiers

    doi: 10.1016/s0140-6736(20)32215-7

    handle: 10261/222977

    Publisher: Lancet Publishing Group

    Lucy Okell and colleagues1 observed that the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently in marked decline in many countries. Okell and colleagues suggest two possible explanations for this decline, namely the effect of lock...

    Add to ORCID
  • other research product . Other ORP type . 2020
    Abnormal Liver Function Tests in Patients WithCOVID-19: Relevance and Potential Pathogenesis
    Embargo English
    Authors:
    Bertolini, Anna; van de Peppel, Ivo P; Bodewes, Frank A J A; Moshage, Han; Fantin, Alberto; Farinati, Fabio; Fiorotto, Romina; Jonker, Johan W; Strazzabosco, Mario; Verkade, Henkjan J; ...
    Persistent Identifiers

    doi: 10.1002/hep.31480

    Abnormal liver function tests (LFTs) are reported frequently in hospitalized coronavirus disease 2019 (COVID-19) patients. A review of the literature shows that 46% of admitted COVID-19 patients had elevated plasma aspartate aminotransferase (AST) and 35% had elevated a...

    Add to ORCID
6 research outcomes, page 1 of 1